Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1000 of 3173 entries
View as:

A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.

Phase: N/A Priority: Normal
NCT ID: NCT00077974 Org: User:
Start: 02/29/04 End: 09/30/08 Due: 09/30/09

A First In Human Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of PF-04455242 In Single Rising Doses In Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00938301 Org: User:
Start: 04/30/09 End: 07/31/09 Due: 07/31/10

Special Investigation For Gist Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan).

Phase: N/A Priority: Normal
NCT ID: NCT00716820 Org: User:
Start: 04/30/08 End: 09/30/16 Due: 09/30/17

A Single Dose Study Of PF-04620110 In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01166217 Org: User:
Start: 07/31/10 End: 08/31/10 Due: 08/31/11

Study to Evaluate the Safety and Immunogenicity of Nimenrix (Registered) in Healthy Infants, Given at 3 and 12 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT04819113 Org: User:
Start: 04/09/21 End: 09/09/22 Due: 09/09/23

Azithromycin Microspheres in Patients With Low Risk Community Acquired Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT00140023 Org: User:
Start: 09/30/05 End: 06/30/06 Due: 06/30/07

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)

Phase: N/A Priority: Normal
NCT ID: NCT00444925 Org: User:
Start: 04/30/07 End: 07/31/08 Due: 07/31/09

Study To Examine Effect Of CP-866,087 On Consumption And Craving Of Alcohol In Alcohol Dependent Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT00147576 Org: User:
Start: 12/31/03 End: 12/31/04 Due: 12/31/05

Effect of Linezolid on Ex Vivo Neutrophil and Monocyte Function in Healthy Males

Phase: N/A Priority: Normal
NCT ID: NCT01544673 Org: User:
Start: 03/31/12 End: 04/30/12 Due: 04/30/13

Post-Authorisation Safety Cohort Observation of RetacritTM (Epoetin Zeta) Administered Subcutaneously for the Treatment of Renal Anaemia

Phase: N/A Priority: Normal
NCT ID: NCT01543477 Org: User:
Start: 07/07/10 End: 04/29/20 Due: 04/29/21

Study Examing The Effect Of Omeprazole On Safety, Tolerability And How The Body Processes An Experimental Drug

Phase: N/A Priority: Normal
NCT ID: NCT00644839 Org: User:
Start: 04/30/08 End: 07/31/08 Due: 07/31/09

A Study of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or Metastatic RAS-mutant Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03637491 Org: User:
Start: 08/15/18 End: 02/02/21 Due: 02/02/22

A Study to Assess the Safety, Tolerability and Pharmacokinetics of NXL104 Alone and in Combination With Ceftazidime Administered as Single and Repeated Intravenous Doses in Healthy Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01291602 Org: User:
Start: 02/28/11 End: 04/30/11 Due: 04/30/12

A Study to Demonstrate the Equivalence of the Tofacitinib Oral Solution to the Tablet Formulation in Healthy Participants.

Phase: N/A Priority: Normal
NCT ID: NCT04111614 Org: User:
Start: 10/11/19 End: 12/12/19 Due: 12/12/20

A Single Dose Study Of PF-06291874 In Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01499017 Org: User:
Start: 11/30/11 End: 01/31/12 Due: 01/31/13

A Study of Azithromycin in the Prevention of Mycobacterium Avium Complex Disease (MAC) in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00002309 Org: User:
Start: - End: - Due: -

A Study to Learn How Different Amounts of the Study Medicine Called PF-07999415 Are Tolerated and Act in the Body in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06965465 Org: User:
Start: 06/23/25 End: 03/28/26 Due: 03/28/27

Drug-Drug Interaction Study With PF-05089771

Phase: N/A Priority: Normal
NCT ID: NCT01934569 Org: User:
Start: 09/30/13 End: 11/30/13 Due: 11/30/14

Switchover Trial From Imiglucerase to Plant Cell Expressed Recombinant Human Glucocerebrosidase

Phase: N/A Priority: Normal
NCT ID: NCT00712348 Org: User:
Start: 12/31/08 End: 05/31/13 Due: 05/31/14

A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza

Phase: N/A Priority: Normal
NCT ID: NCT05160636 Org: User:
Start: 01/31/22 End: 02/28/26 Due: 02/28/27

GBT021601-022: A Study of GBT021601 in Participants With Sickle Cell Disease (SCD)

Phase: N/A Priority: Normal
NCT ID: NCT05632354 Org: User:
Start: 01/05/23 End: 02/13/25 Due: 02/13/26

Drug Use Investigation Of Azithromycin IV For Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)

Phase: N/A Priority: Normal
NCT ID: NCT01671280 Org: User:
Start: 09/20/12 End: 04/22/16 Due: 04/22/17

Multiple Dose Escalation Trial Of PF-04308515 In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01101932 Org: User:
Start: 03/31/10 End: 11/30/10 Due: 11/30/11

Avelumab In Patients With Previously Treated Advanced Stage Classical Hodgkin's Lymphoma (JAVELIN HODGKINS)

Phase: N/A Priority: Normal
NCT ID: NCT02603419 Org: User:
Start: 03/10/16 End: 04/11/19 Due: 04/11/20

Evaluation Of PF-00572778 And Alprazolam On Naloxone Challenge In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00580190 Org: User:
Start: 09/30/07 End: 02/29/08 Due: 02/28/09